FDA Investigator Melissa B Libby
Melissa B Libby has inspections in 3 countries as of 31 Oct 2023. Melissa B Libby has collaborated with a combinined 3456 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
265
Last Inspection Date:
31 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Poland,
Ireland
Co-Investigator(s):
Addie V Scott Boston,
Adriana N Jimenez Lopez,
Alan D Centi,
Albert M Brindle,
Alberto A Viciedo,
Alejandra Mcclellan,
Allen Lou,
Amber G Chung,
Amy L Singer,
Amy M Codella,
Amy M Cramer,
Amy W Yan Mai,
Ana S Cabrera,
Andrew F Cohen,
Andrew J Molesky,
Anita R Michael,
Anthony M Criscuolo, Jr,
Audrey Thereset Uy,
Bailey,
Barbara J Maulfair,
Barbara Jwilimczyk Macri,
Brandi L Garbutt,
Brian R Yaun,
Brian Ravitch,
Cara M Minelli,
Carol A Perry,
Carol A Robles,
Cary Greene,
Celia L Hutchinstein,
Chamberlain,
Charisse K Green,
Charles J Chacko,
Charlotte P Chang,
Christina N Maurino,
Christine M Cerenzio,
Christopher L Taste,
Colin E Tack,
Cordero T Kimbrell,
Craig W Swanson,
Crystal A Harlan,
Daniel J Grabicki,
Daniel W Johnson,
Dariusz Galezowski,
Darlene C Plank Turlington,
David H Smith,
David L Pearce,
David R Delucia,
Dawn D Aiello,
Dawn L Wydner,
Deborah B Nixon,
Debra J Bennett,
Denise M Visco, Investigator,
Dhaval H Patel,
Diane B Radice,
Doreen P Gubbay,
Douglas C Kovacs,
Edward D Mcdonald,
Edward Oshaughnessy,
Elizabeth P Mayer,
Emest F Bizjak,
Emmanuel J Ramos,
Eric J Cunningham,
Eric Rothschild,
Erika M Wilkerson,
Erin D Mccaffery,
Frank J Marciniak,
Frederick Razzaghi,
Gayle S Lawson,
Gerald W Kopp,
Gianine E Delade,
Gianine E Tompkins,
Gray,
Guerlain Ulysse,
Helen B Ricalde,
Helen Verdel,
Herrmann,
Hitesh R Patel,
Iram R Hassan, PhD,
Jacqueline A O'shaughnessy, PhD,
Jamie D Swann,
Jason Kwong,
Jason M Sluzynski,
Jeffrey J Ebersole,
Jennifer Macmillan,
Jessica M Monteiro,
Jill M Sooter,
Jogy George,
Jonee J Mearns,
Joseph Duca,
Joseph F Mcginnis, RPh,
Joseph H Procopio,
Joseph S Fanelli,
Joshua C Schafer,
Joy F Canlas,
Joy P Matthias,
Joy Rkozlowski Klena,
Judith A Paterson,
Justin C Fuller,
Karen A Spencer,
Karen E D'orazio,
Karen F Tomaziefski,
Keith M Reilly,
Kelli F Dobilas,
Kelly Doremus,
Kelly I Anderson,
Kerry A Donovan,
Kerry A Kurdilla,
King,
Kris K Moore,
Kristina J Donohue,
Kristy A Zielny,
Krystal O Ogunremi,
Kyle D Covill,
Kyle S Hobson,
Laishan L Lam,
Larry Johnson,
Lata C Mathew, PhD,
Lawrence R Johnson,
Li Li,
Liatte Kreuger, PharmD,
Liattle Krueger,
Lisa Mathew,
Marcelo O Mangalindan, Jr,
Marea K Harmon,
Margaret M Sands,
Maria Estrella,
Marjorie D Schultz,
Megan E Kulas,
Melba Trivera Clavell,
Melissa M Dauksis,
Melissa M Schafer,
Melissa T Roy,
Meredith L Sheridan,
Meyer,
Michael A Feingold,
Michael R Klapal,
Michael Rosner,
Michael Serrano,
Miguel G Manzano,
Monika Borkowska,
Nancy F Scheraga,
Nancy M Espinal,
Neil J Bonzagni, PhD MPH,
Nerizza B Guerin,
Niketa Patel,
Nikki S Ramirez,
Nina Yang,
Omolola A Shola Philips,
Paterson,
Paul L Bellamy,
Pedro A Cruz,
Perez,
Peter M Trunk,
Peter R Lenahan,
Phares O Okelo,
Phillip O Mathis,
Raffi B Papazian,
Randolph Campos Santiago,
Raymond L Cheung,
Raymond M Lam,
Regina T Brown,
Remache,
Rene M Amaguana,
Richard D Manney,
Rina Bhikha,
Robert D Tollefsen,
Robert P Neligan,
Robert W Calais,
Rodrigo Vilchez,
Ronald Ifraimov,
Rose Ljean Mary,
Saleem A Akhtar,
Sandra Kershaw,
Sands,
Sarah Forney,
Schultz,
Sean D Duke,
Sherri J Liu,
Shreya Shah,
Sinai Davis,
Sonia D Hudson,
Sonia E Ortiz,
State Agency,
Stephanie T Durso,
Stephen J Mottola,
Steven S Wahl,
Susan M Halsted,
Tania E Vizcaino,
Tara G Bizjak,
Teigan M Mule,
Thomas E Friel,
Todd J Maushart,
Tonia F Bernard,
Tressa T Lewis,
Vaishali J Patel,
Valerie C Reed,
Wayne J Meyer,
William J Muszynski,
Willy A Orantes,
Yasmin B Rios,
Yvesna C Blaise,
Yvins Dezan,
Zakaria I Ganiyu
Melissa B Libby's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2014 | EIR | ABBOTT IRELAND LIMITED - EIR, 2014-06-30 |
February, 2014 | FDA 483 | Organics Corporation of America DBA Ambix Laboratories - Form 483, 2014-02-24 |
March, 2019 | EIR | DSM Nutritional Products, LLC - EIR, 2019-03-14 |
December, 2017 | FDA 483 | Red Ribbon Bakeshop Inc. - Form 483, 2017-12-13 |
June, 2015 | EIR | Amazon Forest, Inc. - EIR, 2015-06-17 |
January, 2018 | EIR | Manhattan Drug Co. Inc - EIR, 2018-01-25 |
October, 2019 | EIR | Givaudan Flavor Corp. - EIR, 2019-10-08 |
January, 2017 | EIR | W.Y. Industries, Inc. - EIR, 2017-01-05 |
September, 2010 | FDA 483 | Pharmachem Laboratories LLC - Form 483, 2010-09-24 |
May, 2019 | EIR | Nutricia North America - EIR, 2019-05-14 |
August, 2015 | EIR | Darling Ingredients, Inc. - EIR, 2015-08-10 |
January, 2013 | EIR | ChemAid Laboratories, Inc. - EIR, 2013-01-30 |
September, 2012 | FDA 483 Response | N.V.E. Pharmaceuticals, Inc. - Form 483R, 2013-01-15 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more